Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More
Sell VIP Industries, it may slip further, says Sudarshan Sukhani of s2analytics.com.
Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.
Orchid Chemicals set for huge forex losses on FCCB, says SP Tulsian, sptulsian.com.
Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.
Sell Orchid Chemicals, says Sudarshan Sukhani of s2analytics.com.
SP Tulsian, sptulsian.com shares his comments on Orchid Chemicals.
Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.
Orchid Chemical may rally upto Rs 180-190, says SP Tulsian, sptulsian.com.
Buy Cipla 320 call, says VK Sharma, HDFC Securities.
On CNBC-TV18's new show Super Six, market gurus Hemen Kapadia, CEO of chartpundit.com, Rakesh Gandhi, Sr Technical Analyst of LKP and Vishal B Malkan, CMT, www.malkansview.com, place their bets on two stocks each, thus offering investors a variety of options to choose from.
Short Orchid Chemicals, says Sudarshan Sukhani of technicaltrends.com.
Sudarshan Sukhani of Technical Trends is of the view that one should avoid Aurobindo Pharma.
Short Aurobindo Pharma, says Sudarshan Sukhani of technicaltrends.com.
SP Tulsian of sptulsian.com shares his view on Orchid Chemical.
Buy Orchid Chemicals, says Sudarshan Sukhani, Technical Trends.
Orchid Chemicals may rally upto Rs 245- 250 in next six months, says SP Tulsian, sptulsian.com.
Rakesh Bansal, CEO of rakeshbansal.com is of the view that one should hold Orchid Chemicals.
Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.
Orchid Chemicals may test Rs 220- 225, says SP Tulsian, sptulsian.com
Buy Orchid Chemicals, says SP Tulsian of sptulsian.com
Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.
SP Tulsian of sptulsian.com view on Sintex, Orchid Chemicals.
Orchid Chemicals can slip to Rs 135, says Puneet Kinra of Bonanza Portfolio.
Keep Rs 197 stoploss in Orchid Chemicals, says Anu Jain, Vice President, IIFL Private Wealth Management.
Shardul Kulkarni of Angel Broking feels that one should exit Orchid Chemicals.